Transgenic mice expressing mutated forms of the gene for the human amyloid precursor protein (hAPP) and show a marked elevation in Aβ-protein level and Aβ deposition in the cerebral cortex and hippocampus [11–13] and develop similar neuropathological hallmarks to those observed in AD brains. Here, APP is linked to Alzheimer disease.